title: Biochemical characterization of nuclear receptors for vitamin D3 and glucocorticoids in prostate stroma cell microenvironment.
abstract: The disruption of stromal cell signals in prostate tissue microenvironment influences the development of prostate cancer to androgen independence. 1α,25-Dihydroxyvitamin D(3) (1,25D(3)) and glucocorticoids, either alone or in combination, have been investigated as alternatives for the treatment of advanced prostate cancers that fails androgen therapies. The effects of glucocorticoids are mediated by the intracellular glucocorticoid receptor (GR). Similarly, the effect of 1,25D(3) is mediated by the 1,25D(3) nuclear receptor (VDR). In this study, fibroblasts from benign- (BAS) and carcinoma-associated stroma (CAS) were isolated from human prostates to characterize VDR and GR function as transcription factors in prostate stroma. The VDR-mediated transcriptional activity assessed using the CYP24-luciferase reporter was limited to 3-fold induction by 1,25D(3) in 9 out of 13 CAS (70%), as compared to >10-fold induction in the BAS clinical sample pair. Expression of His-tagged VDR (Ad-his-VDR) failed to recover the low transcriptional activity of the luciferase reporter in 7 out of 9 CAS. Interestingly, expression of Ad-his-VDR successfully recovered receptor-mediated induction in 2 out of the 9 CAS analyzed, suggesting that changes in the receptor protein itself was responsible for decreased response and resistance to 1,25D(3) action. Conversely, VDR-mediated transcriptional activity was more efficient in 4 out of 13 CAS (30%), as compared to the BAS sample pair. Consistent with the reduced response to 1,25D(3) observed in CAS, chromatin immunoprecipitation (ChIP) assays indicated decreased recruitment of coactivators SRC-1/CBP, without major changes in the recruitment of VDR to the CYP24 promoter. In addition, we observed that GR-mediated transcriptional activity was also altered in CAS, as compared to BAS. Disruption of coactivators SRC-1/CBP recruitment may promote hormone resistance in CaP, and highlights the relevance of molecular diagnosis and drug design in tumor cell microenvironment.
authors.affiliation: Laboratory of Molecular Endocrinology, Department of Physiopathology, University of Concepcion, Concepcion, Chile.
authors.forename: Alejandro A
authors.initials: AA
authors.lastname: Hidalgo
authors.forename: Viviana P
authors.initials: VP
authors.lastname: Montecinos
authors.forename: Roberto
authors.initials: R
authors.lastname: Paredes
authors.forename: Alejandro S
authors.initials: AS
authors.lastname: Godoy
authors.forename: Eileen M
authors.initials: EM
authors.lastname: McNerney
authors.forename: Heribelt
authors.initials: H
authors.lastname: Tovar
authors.forename: Diego
authors.initials: D
authors.lastname: Pantoja
authors.forename: Candace
authors.initials: C
authors.lastname: Johnson
authors.forename: Donald
authors.initials: D
authors.lastname: Trump
authors.forename: Sergio A
authors.initials: SA
authors.lastname: Onate
mesh_terms: D002467:Cell Nucleus / Q000378:metabolism*; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D008297:Male; D056920:Nuclear Receptor Coactivator 1 / Q000378:metabolism; D011471:Prostatic Neoplasms / Q000235:genetics* / Q000378:metabolism; D018167:Receptors, Calcitriol / Q000235:genetics / Q000378:metabolism*; D011965:Receptors, Glucocorticoid / Q000235:genetics / Q000378:metabolism*; D017154:Stromal Cells / Q000378:metabolism; D014407:Tumor Cells, Cultured; D059016:Tumor Microenvironment / Q000235:genetics*
chemical_list: D018167:Receptors, Calcitriol; D011965:Receptors, Glucocorticoid; D056920:Nuclear Receptor Coactivator 1